Economic foundations of cost-effectiveness analysis

Journal of Health Economics

Volumn 16, Issue 1, 1997, Pages 1-31

  Garber, Alan M ^a,b,c   Phelps, Charles E ^c,d  

^a VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL BUREAU OF ECONOMIC RESEARCH   (United States)

^d UNIVERSITY OF ROCHESTER   (United States)

Author keywords

Cost benefit analysis; Cost effectiveness analysis; Health care costs; Utility maximization; Welfare economics

Indexed keywords

ANALYTIC METHOD; ARTICLE; COST EFFECTIVENESS ANALYSIS; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH ECONOMICS; HEALTH INSURANCE; HEALTH PROGRAM; RESOURCE ALLOCATION; WELFARE;

COST-BENEFIT ANALYSIS; HEALTH CARE COSTS; HEALTH POLICY; HEALTH SERVICES RESEARCH; MODELS, ECONOMETRIC; QUALITY-ADJUSTED LIFE YEARS; UNITED STATES;

EID: 0030919507     PISSN: 01676296     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-6296(96)00506-1     Document Type: Article

References (53)

1. Arrow, K.J., 1974, Essays in the theory of risk bearing (North-Holland, Amsterdam).
2. Avorn, J., 1984, Benefit and cost analysis in geriatric care: Turning age discrimination into health policy, New England Journal of Medicine 310, 1294-1301.
3. Barro, R.J., 1987, Macroeconomics, 2nd edn. (Wiley, New York).
4. Becker, G.S. and K.M. Murphy, 1988, A theory of rational addiction, Journal of Political Economy 96, 675-700.
5. Blume, M.E. and I.E. Friend, 1975, The asset structure of individual portfolios and some implications for utility functions, Journal of Finance 30, 585-603.
6. Boyle, M.H., G.W. Torrance, J.C. Sinclair and S.P. Horwood, 1983, Economic evaluation of neonatal intensive care of very-low-birth-weight infants, New England Journal of Medicine 308, 1330-1337.
7. Browner, W.S., J. Westenhouse and J.A. Tice, 1991, What if Americans ate less fat? A quantitative estimate of the effect on mortality, Journal of the American Medical Association 265, 3285-3291.
8. Caballero, R.J., 1991, Earnings uncertainty and aggregate wealth accumulation, American Economic Review 81, 859-871.
9. Cropper, M.L., S.K. Aydede and P.R. Portney, 1992, Rates of time preference for saving lives, American Economic Review 82, 469-472.
10. Culyer, A.J., 1991, The normative economics of health care finance and provision, in: A. McGuire, P. Fenn and K. Mayhew, eds., Providing health care (Oxford University Press, Oxford).
11. Cummings, S.R., S.M. Rubin and G. Oster, 1989, The cost-effectiveness of counseling smokers to quit, Journal of the American Medical Association 261, 75-79.
12. Drummond, M.F., G.L. Stoddart and G.W. Torrance, 1987. Methods for the economic evaluation of health care programmes (Oxford University Press, Oxford).
13. Eddy, D.M., 1989, Screening for breast cancer, Annals of Internal Medicine 111, 389-399.
14. Eddy, D.M., 1990, Screening for cervical cancer, Annals of Internal Medicine 113, 214-226.
15. Ehrlich, I. and G.S. Becker, 1972, Market insurance, self-insurance, and self-protection, Journal of Political Economy 80, 623-648.
16. Farber, H.S., 1978, Individual preferences and union wage determination, Journal of Political Economy 86, 923-942.
17. Friend, I.E. and M.E. Blume, 1975, The demand for risky assets, American Economic Review 65, 900-923.
18. Fuchs, V.R., 1982, Time preference and health: An exploratory study, in: V.R. Fuchs, ed., Economic aspects of health (University of Chicago Press, Chicago), 93-120.
19. Garber, A.M., W.S. Browner and S.B. Hulley, 1996a, Cholesterol screening in asymptomatic adults, revisited, Annals of Internal Medicine 124, 518-531.
20. Garber A.M., M.C. Weinstein, G.W. Torrance and M.S. Kamlet, 1996, Theoretical foundations of cost-effectiveness analysis, in: M.R. Gold, J.E. Siegel, L.B. Russell and M.E. Weinstein, eds., Cost-effectiveness in health and medicine (Oxford University Press, New York).
21. Goldman, L., M.C. Weinstein, P.A. Goldman and L.W. Williams, 1991, Cost-effectiveness of HMG-CoA reductase inhibition for primary and secondary prevention of coronary heart disease, Journal of the American Medical Association 265, 1145-1151.
22. Gruber, J. and B.C. Madrian, 1995, Health insurance availability and the retirement decision, American Economic Review 85, 938-948.
23. Hall, R.E., 1988, Intertemporal substitution, Journal of Political Economy 96, 339-357.
24. Hanemann, W.M., 1991, Willingness to pay and willingness to accept: How much can they differ? American Economic Review 81, 635-647.
25. Hansen, L.P. and K.J. Singleton, 1983, Stochastic consumption, risk aversion, and the temporal behavior of asset returns, Journal of Political Economy 91, 249-265.
26. Hirshleifer, J., 1966, Investment under uncertainty: Applications of the state-preference approach, Quarterly Journal of Economics 80, 252-277.
27. Kamlet, M.S., 1992, The comparative benefits modeling project: A framework for cost-utility analysis of government health care programs (Office of Disease Prevention and Health Promotion, Public Health Service, US Department of Health and Human Services, Washington, DC).
28. Keeler, E.B. and S. Cretin, 1983, Discounting of life-saving and other nonmonetary effects, Management Science 29, 300-306.
29. Littenberg, B., A.M. Garber and H.C. Sox, Jr., 1990, Screening for hypertension, Annals of Internal Medicine 112, 192-202.
30. Litzenberger, R.H. and E.I. Ronn, 1986, A utility-based model of common stock price movements, Journal of Finance 15, 67-92.
31. Miyamako, J.M. and S.A. Eraker, 1985, Parameter estimates for a QALY utility model, Medical Decision Making 5, 191-213.
32. National Center for Health Statistics, 1996, Vital statistics of the United States, 1992: vol. II, sec. 6 Life tables (US Public Health Service, Washington, DC).
33. Office of Technology Assessment, US Congress, 1981, Cost effectiveness of influenza vaccination (US Government Printing Office, Washington, DC).
34. Pauly, M.V., 1986, Taxation, health insurance, and market failure in the medical economy, Journal of Economic Literature 24, 629-675.
35. Pauly, M.V., 1995. Valuing health benefits in money terms, in: F.A. Sloan, ed., Valuing health care: Costs, benefits, and effectiveness of pharmaceutical and other medical technologies (Cambridge University Press, Cambridge, UK) 99-124.
36. Phelps, C.E. and A.I. Mushlin, 1991, On the (near) equivalence of cost effectiveness and cost benefit analysis, International Journal of Technology Assessment in Health Care 7, 12-21.
37. Pliskin, J.S., D.S. Shepherd and M.C. Weinstein, 1980, Utility functions for life years and health status, Operations Research 28, 206-224.
38. Pratt, J.W., 1964, Risk aversion in the small and in the large, Econometrica 32, 122-136.
39. Riddiough, M.A., J.E. Sisk and J.C. Bell, 1983, Influenza vaccination: Cost-effectiveness and public policy, Journal of the American Medical Association 249, 189-195.
40. Russell, L.B., 1986, Is prevention better than cure? (Brookings Institution, Washington, DC).
41. Russell, L.B., J.E. Siegel, N. Daniels, M.R. Gold, B.R. Luce and J.S. Mandelblatt, 1996, Cost-effectiveness analysis as a guide to resource allocation in health: Roles and limitations, in M.R. Gold, J.E. Siegel, L.B. Russell and M.E. Weinstein, eds., Cost-effectiveness in health and medicine (Oxford University Press, New York).
42. Siegel, F.W. and J.P. Hoban, 1982, Relative risk aversion revisited, Review of Economics and Statistics 64, 481-487.
43. Sox, H.C. Jr., B. Littenberg and A.M. Garber, 1989, The role of exercise testing in screening for coronary artery disease, Annals of Internal Medicine 110, 456-469.
44. Szpiro, G.A., 1986, Measuring risk aversion: An alternative approach, Review of Economics and Statistics 68, 156-159.
45. Tolley, G., D. Kenkel, R. Fabian and D. Webster, 1994, The use of health values in policy, in: G. Tolley, D. Kenkel and R. Fabian, eds., Valuing health for policy (University of Chicago Press, Chicago), 345-391.
46. Torrance, G.W., 1986, Measurement of health state utilities for economic appraisal, Journal of Health Economics 5, 1-30.
47. Torrance, G.W., 1987, Utility approach to measuring health-related quality of life, Journal of Chronic Diseases 40, 593-600.
48. Viscusi, W.K. and M.J. Moore, 1989, Rates of time preference and valuations of the duration of life, Journal of Political Economy 38, 297-317.
49. Weber, W.E., 1970, The effects of interest rates on aggregate consumption, American Economic Review 60, 591-600.
50. Weber, W.E., 1975, Interest rates, inflation and consumer expenditures, American Economic Review 65, 843-858.
51. Weinstein, M.C., 1981, Economic assessment of medical practices and technologies, Medical Decision Making 1, 309-330.
52. Weinstein, M.C. and H.V. Fineberg, 1980, Clinical decision analysis (W.B. Saunders. Philadelphia).
53. Williams, A., 1993. Cost-benefit analysis: Applied welfare economics or general decision aid. in: A. Williams and E.Giardina, eds., Efficiency in the public sector (Edward Elgar, London).